The Research Landscape Patients Rarely See
Around five million people in the UK live with diabetes, and the NHS treats research as a core part of routine care. Universities, hospital trusts and pharmaceutical companies run thousands of studies, and many struggle to find enough volunteers. Trials are registered on public databases such as ClinicalTrials.gov and the ISRCTN registry, while charities like Diabetes UK and Breakthrough T1D maintain dedicated pages listing current opportunities.
Yet most patients never hear about them. Your GP might mention a study if you happen to ask, but there is no automatic alert telling you that a trial in Leicester is looking for someone like you. The barriers are practical as much as medical. A parent in Manchester juggling school runs and work may struggle to commit to hospital visits in London. Others worry that volunteering for a new treatment means handing over control of their own care.
The good news is that research teams have noticed. More type 2 diabetes clinical trials now offer online participation, flexible appointment windows and generous travel expense arrangements.
What the Latest UK Trials Are Actually Testing
The range of diabetes research trials open in the UK right now is wider than most people imagine.
For type 1 diabetes, hybrid closed loop systems, sometimes called artificial pancreas technology, have moved from science fiction into everyday trials. The NHS ran one of the world's first nationwide tests of these systems, which monitor glucose constantly and adjust insulin automatically through a pump. Newer studies continue to examine how well the technology works across different age groups and lifestyles, with the aim of reducing finger prick tests and preventing dangerous highs and lows.
For type 2 diabetes, the NHS Type 2 Diabetes Path to Remission programme, better known as the soups and shakes plan, has been a genuine turning point. Data published by NHS England showed that among people who completed the programme, around one in three put their diabetes into remission, with an average weight loss of close to 16kg. The programme replaces meals with low-calorie soups and shakes for several months, then gradually reintroduces food with professional guidance.
Continuous glucose monitoring is another focus. A study running in primary care settings across the UK and Ireland is testing the Dexcom ONE+ system for people with type 2 diabetes who use insulin, checking whether real-time glucose readings improve control and ease the burden on general practice.
Digital trials are growing too. Researchers at the University of the West of England are recruiting adults with type 1 or type 2 diabetes for a four-week online programme built around psychological and behaviour change techniques, designed to reduce diabetes distress. A separate team at City St George's in London is studying a digital tool that helps people build healthier eating habits.
Commercial drug studies add another layer. A Phase 2 trial sponsored by Eli Lilly, comparing an investigational treatment against placebo in people already on stable doses of semaglutide or tirzepatide, is recruiting at sites in Birmingham, Blackpool, Bristol and Newcastle. These paid diabetes trials UK offer a different route, often with compensation for time and travel.
A Patient Story: James from Leeds
James, a 47-year-old teacher from Leeds, spent six years managing type 2 diabetes with metformin before his nurse mentioned the remission programme during a routine review. "I assumed trials were only for people with severe disease," he says. "Nobody had told me I could join something designed to get me off medication."
He took part in the Path to Remission programme, lost over a stone, and has kept his blood sugar in a healthier range ever since. For James the appeal was practical: the structure was clear, the support came from his own NHS team, and the only real cost was discipline. Not every story ends in remission, but his shows that the biggest barrier is often simply not knowing the option exists.
Comparing the Main Options
| Trial type | Real UK example | Commitment | Cost or compensation | Best suited to | Main benefits | Things to consider |
|---|
| Hybrid closed loop | NHS-led type 1 trial across 35 centres | Device worn daily, regular reviews | Covered through NHS research funding | People with type 1 wanting fewer daily checks | Automated insulin dosing, fewer highs and lows | Device training, ongoing follow-up |
| Continuous glucose monitoring | Dexcom ONE+ primary care study | Sensor worn over several months | Covered by the study, travel expenses paid | Adults with type 2 on insulin | Real-time glucose data, fewer finger pricks | Sensor wear takes some getting used to |
| Diet-based remission | NHS Path to Remission programme | Around 12 months including follow-up | Provided through the NHS programme | Recently diagnosed type 2 patients | About one in three completers reached remission | Low-calorie phase demands commitment |
| Digital wellbeing | UWE Bristol online study | Four weeks, fully remote | Covered, no travel required | Adults with type 1 or type 2 | Less diabetes distress, flexible timing | Self-guided, needs self-discipline |
| Commercial drug trial | Eli Lilly Phase 2 study | Several visits over months | Compensation in the low thousands | Adults on stable GLP-1 treatment | Access to investigational treatment, payment | Placebo possible, strict eligibility rules |
How to Find a Trial Near You
Start with your own GP or diabetes nurse. They can tell you whether you are eligible for local research and flag anything that might interfere with your current treatment.
Then use the registries. ClinicalTrials.gov and the ISRCTN registry let you filter by condition and location, so you can search for type 2 diabetes trials in Birmingham or type 1 diabetes research trials in Scotland. Diabetes UK publishes a clinical trials page updated regularly, and Breakthrough T1D lists studies specifically for type 1. If you live in Scotland, signing up to the NHS Research Scotland Diabetes Register means you can be matched with relevant studies automatically.
Before you apply, check the eligibility criteria carefully. Most studies specify an age range, a diagnosis duration and an HbA1c window. The Dexcom study, for instance, looks for adults who have had type 2 diabetes for at least three months and use insulin, with a recent HbA1c above 6.5%. The Eli Lilly trial requires a stable dose of certain GLP-1 medications. If you do not match, do not be discouraged; studies start and finish all the time.
What to Ask Before You Say Yes
Treat the first conversation with a research team as a two-way interview. Ask how many visits are involved and where they take place. Ask who to call if you have problems outside clinic hours. Ask what happens when the trial ends and whether the treatment remains available.
Compensation varies. NHS-led research typically covers travel and does not ask participants to pay for the care involved, while commercial studies often pay for time and inconvenience. One type 2 trial at a UK unit, for example, offered compensation in the region of £3,000 to £4,000 for a 17-night inpatient stay, with travel expenses on top. Do not assume every study pays this much, and never join one purely for the money. The value is real either way: you gain access to specialists, close monitoring and new technology that may improve your control.
A Practical Next Step
The best time to look at diabetes management trials is before you feel you need them. Book a routine review, ask your care team what research is active in your area, and spend ten minutes on the Diabetes UK trials page. Even if you decide not to take part, knowing what is available puts you in a stronger position to make decisions about your own care. The treatment that could change how diabetes is managed in this country is being tested now, and the people it is designed for are the ones who help decide whether it works.
研究の知恵